Singapore is gateway to Asia as region transitions to electric vehicles.
Ravi Vaidya, Vice President of Sales, APAC and the Middle East, to lead the office.
SINGAPORE–(BUSINESS WIRE)–Tritium Holdings Pty Ltd (�Tritium), a global developer and manufacturer of direct current (DC) fast charging technology for electric vehicles (EVs), today opened a new office in Singapore. The opening of the new regional office aims to cater to the increase in interest in EVs in Asia-Pacific (APAC) and the Middle East, and to allow the company to have local presence in the region and align more closely with its customers in Asia.
The region has been very proactive in incentivising uptake of electric vehicles, said Jane Hunter, CEO, Tritium. Singapore, for instance, recently launched an EV Early Adoption Incentive and an enhanced Vehicular Emissions Scheme to further close the cost gap between EVs and internal combustion engine vehicles. And, to transform the country into a low-carbon society, Thailand has announced that EVs will contribute to at least 30 percent of total domestic vehicle production by 2030 and the country will be equipped with 12,000 public fast charging stations by that time. These are just two examples of a region-wide push to transition to electric vehicles, and were seeing an increased interest in the installation of publicly-available charging infrastructure as a result.
The region will be led by Ravi Vaidya, who was recently appointed to the role of Vice President of Sales, APAC and the Middle East.
Singapore is the gateway to Asia, and as we look to break into those markets and assist them in deploying fast charging infrastructure, Singapore makes sense as a regional foothold for us, said Ravi Vaidya. Tritiums chargers are perfectly suited to withstand APAC and Middle Eastern environments. Theyre tested and built to withstand dust, wind, humidity, extreme heat and any other environmental condition, and this is what these unique markets need as they transition to electric vehicles.
Tritium, founded in Brisbane, Australia, has provided more than 2.7 million high-power charging sessions from over 5,250 chargers deployed across 46 countries. The company recently secured an AUD$40 million private placement by Cigna Investments, Inc. (Cigna), the investment arm of Cigna Corporation, a U.S.-based global health services company. Part of the private placement is expected to be used to continue scaling its global operations, with Singapore the first stage of that expansion.
About Tritium
Founded in 2001, Tritium designs and manufactures proprietary hardware and software to create advanced and reliable DC fast chargers for electric vehicles. Tritium’s compact and robust chargers are designed to look great on Main Street and thrive in harsh conditions, through technology engineered to be easy to install, own, and use. Tritium is focused on continuous innovation in support of our customers around the world.
As announced on May 26, 2021, Tritium has entered into a definitive agreement for a business combination with Decarbonization Plus Acquisition Corporation II (NASDAQ: DCRN, DCRNW), a publicly traded special purpose acquisition company (SPAC), that would result in Tritium becoming a publicly listed company. Completion of the proposed transaction is subject to customary closing conditions and is expected to occur in the fourth quarter of 2021.
For more information, visit tritiumcharging.com
About Decarbonization Plus Acquisition Corporation II
Decarbonization Plus Acquisition Corporation II is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with a target whose principal effort is developing and advancing a platform that decarbonizes the most carbon-intensive sectors. These include the energy and agriculture, industrials, transportation and commercial and residential sectors. DCRN is sponsored by an affiliate of Riverstone Holdings LLC and represents a further expansion of Riverstone’s 15-year franchise in low-carbon investments, having established industry leading, scaled companies with more than US$5 billion of equity invested in renewables.
No Offer or Solicitation
This document does not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed Business Combination (as defined below). This document also does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor will there be any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities will be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.
Forward-Looking Statements
Certain statements made in this document are forward-looking statements with respect to the proposed transaction (the Business Combination) between DCRN, Tritium and Tritium DCFC Limited, an Australian public company limited by shares (NewCo), and including statements regarding the benefits of the Business Combination, the anticipated timing of the Business Combination, the services offered by Tritium and the markets in which it operates, and NewCos projected future results. These forward-looking statements generally are identified by the words estimates, projected, expects, anticipates, forecasts, plans, intends, believes, seeks, targets, may, will, should, would, will be, will continue, will likely result, future, propose, strategy, opportunity and variations of these words or similar expressions (or the negative versions of such words or expressions) that predict or indicate future events or trends or are not statements of historical matters are intended to identify forward-looking statements. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, guarantees, assurances, predictions or definitive statements of fact or probability regarding future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside NewCos, Tritiums or DCRNs control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include the inability to complete the Business Combination in a timely manner or at all (including due to the failure to receive required stockholder or shareholder, as applicable, approvals, or the failure of other closing conditions such as the satisfaction of the minimum trust account amount following redemptions by DCRNs public stockholders and the receipt of certain governmental and regulatory approvals), which may adversely affect the price of DCRNs securities; the inability of the Business Combination to be completed by DCRNs business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by DCRN; the occurrence of any event, change or other circumstance that could give rise to the termination of the Business Combination; the inability to recognize the anticipated benefits of the proposed Business Combination; the inability to obtain or maintain the listing of NewCos shares on a national exchange following the proposed Business Combination; costs related to the proposed Business Combination; the risk that the proposed Business Combination disrupts current plans and operations, business relationships or business generally as a result of the announcement and consummation of the proposed Business Combination; NewCos ability to manage growth; NewCos ability to execute its business plan and meet its projections; potential disruption in NewCos employee retention as a result of the Business Combination; potential litigation, governmental or regulatory proceedings, investigations or inquiries involving NewCo, Tritium or DCRN, including in relation to the Business Combination; changes in applicable laws or regulations and general economic and market conditions impacting demand for Tritiums or NewCos products and services; and other risks and uncertainties indicated from time to time in the proxy statement/prospectus relating to the proposed Business Combination, including those under Risk Factors therein, and in DCRNs other filings with the Securities and Exchange Commission (the SEC). Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and NewCo and DCRN assume no obligation and do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither NewCo nor DCRN gives any assurance that either NewCo or DCRN will achieve its expectations.
Additional Information about the Business Combination and Where to Find It
In connection with the proposed Business Combination, DCRN and NewCo, which will be the going-forward public company, intend to file a registration statement on Form F-4 (the Registration Statement) with the SEC, which will include a proxy statement/prospectus, and certain other related documents, to be used at the meeting of stockholders to approve the proposed Business Combination. INVESTORS AND SECURITY HOLDERS OF DCRN ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS, ANY AMENDMENTS THERETO AND OTHER RELEVANT DOCUMENTS THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT TRITIUM, DCRN, NEWCO AND THE BUSINESS COMBINATION. The proxy statement/prospectus will be mailed to stockholders of DCRN as of a record date to be established for voting on the proposed Business Combination. Investors and security holders will also be able to obtain copies of the Registration Statement and other documents containing important information about each of the companies once such documents are filed with the SEC, without charge, at the SECs web site at www.sec.gov.
Participants in Solicitation
DCRN and its directors and executive officers may be deemed participants in the solicitation of proxies from DCRNs stockholders with respect to the proposed Business Combination. A list of the names of those directors and executive officers and a description of their interests in DCRN is contained in DCRNs filings with the SEC, including DCRNs Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC on March 31, 2021, and is available free of charge at the SECs web site at www.sec.gov. Additional information regarding the interests of such participants will be set forth in the Registration Statement for the proposed Business Combination when available. NewCo and Tritium and their respective directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of DCRN in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination will be contained in the Registration Statement for the proposed Business Combination when available.
Contacts
Tritium Media Contact
Jack Ulrich
media@tritium.com.au
Tritium Investors Contact
Caldwell Bailey
ICR, Inc.
TritiumIR@icrinc.com
HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…
HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…
JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…
Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…
HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…
CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…